Cellecta
Cellecta, Inc. was founded in April 2006 by one of the chief scientists from Clontech Laboratories. The company was borne out of the need for higher quality, more advanced shRNA and other lentiviral libraries. Their goal was to develop advanced high-throughput (HT) genetic screen technologies and their applications for the discovery and functional characterization of novel therapeutic targets and drugs.